301126 Stock Overview
Engages in the wholesale and retail of pharmaceuticals products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.94 |
| 52 Week High | CN¥13.77 |
| 52 Week Low | CN¥8.39 |
| Beta | 0.83 |
| 1 Month Change | 5.19% |
| 3 Month Change | -0.73% |
| 1 Year Change | 3.50% |
| 3 Year Change | -36.76% |
| 5 Year Change | n/a |
| Change since IPO | -53.84% |
Recent News & Updates
Recent updates
Some Shareholders Feeling Restless Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) P/E Ratio
Mar 14
There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump
Oct 08Optimistic Investors Push Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Shares Up 30% But Growth Is Lacking
May 09Market Might Still Lack Some Conviction On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Even After 31% Share Price Boost
Mar 08Shareholder Returns
| 301126 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 3.6% | 0.5% | -0.4% |
| 1Y | 3.5% | -2.0% | 8.4% |
Return vs Industry: 301126 exceeded the CN Healthcare industry which returned -2.6% over the past year.
Return vs Market: 301126 underperformed the CN Market which returned 8.5% over the past year.
Price Volatility
| 301126 volatility | |
|---|---|
| 301126 Average Weekly Movement | 9.3% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 301126's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 301126's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 3,461 | Shengli Hu | www.djwk.com.cn |
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. The company offers anabolic preparations and peptide hormones, second-class psychotropic drugs, vaccines, antibiotic raw materials, biological products, biochemical drugs, antibiotic preparations, Chinese medicine decoction pieces, chemical drug preparations, chemical raw materials, Chinese herbal medicines, Chinese patent medicines, and medical toxic drugs; medical devices; and health food products. It also provides pharmaceutical logistics services; and operates reproductive hospitals.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Fundamentals Summary
| 301126 fundamental statistics | |
|---|---|
| Market cap | CN¥2.25b |
| Earnings (TTM) | CN¥26.57m |
| Revenue (TTM) | CN¥5.23b |
Is 301126 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301126 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.23b |
| Cost of Revenue | CN¥4.19b |
| Gross Profit | CN¥1.04b |
| Other Expenses | CN¥1.01b |
| Earnings | CN¥26.57m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 19.88% |
| Net Profit Margin | 0.51% |
| Debt/Equity Ratio | 170.5% |
How did 301126 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 02:04 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.